CPI2 can specifically inhibit the activity of CTSS, block the excessive activation of the inflammatory signaling pathway, reduce the production of pro-inflammatory cytokines, and may also regulate the C5a-C5aR1 axis, thereby alleviating the inflammatory and oxidative stress responses and improving the symptoms of gouty arthritis. The gene discussed is C5AR1; the disease is gout.